BTG International Limited (2006) Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl patty acid glycerol monoesters. PCT/GB2006/000778.

Full text not available from this repository.

Abstract

A method of treating a patient in need of therapy for a cytokine dysregulation comprising administering to that patient a therapeutically effective dose of a monoglyceride or metabolic precursor thereof of general formula (I), wherein R1 is the a fatty acyl group of an essential poyunsaturated fatty acid selected from ϝ-linolenoyl, ϝ-dihomolinolenoyl and arachidonoyl.

Item Type:	Patent
Additional Information:	Pub. No.: WO/2006/092622 International Application No.: PCT/GB2006/000778 Publication Date: 08.09.2006 International Filing Date: 02.03.2006
Uncontrolled Keywords:	Polyunsaturated fatty acids, neurodegenerative diseases
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Related URLs:	Organisation
Last Modified:	09 Oct 2021 04:46
URI:	http://gala.gre.ac.uk/id/eprint/4324

Actions (login required)

View Item